Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heterologous Aerosolized Ad5-nCoV Booster in Adults Primed with Inactivated COVID-19 Vaccine
NCT05204589Phase 3Completed
- Sponsor
- Jiangsu Provincial Center for Disease Control and Prevention
- Start
- Jan 2022
- Primary completion
- Apr 2022
- Modality
- Viral Vectors, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of ad5-ncov in coronavirus disease 2019 (COVID-19), sponsored by Jiangsu Provincial Center for Disease Control and Prevention. Started Jan 2022; status: completed.
02
Drugs
ad5-ncov
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05204589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05204589.